At Serenity, we are committed to following the latest updates in medical research. We strive to offer effective care for our patients through evidence-based treatments beyond talk therapy and medication, and our team is highly knowledgeable in the newest treatment options for depression, anxiety, and other mental illnesses.
2018
This letter certified the Brainsway Deep TMS system for use in treatment of Obsessive-Compulsive Disorder.
Brainsway Ltd, United States Food and Drug Administration
FDA
2014
There was a significant reduction in reported symptoms from 62.5% of study participants over the long-term follow-up period. TMS appears to be an effective long-term treatment for depression.
Center for Anxiety and Depression, Stanford University, Columbia University
The Journal of Clinical Psychiatry
2020
“Approximately two-thirds of people with depression don’t get adequate relief from the first antidepressant they try . . . and each subsequent medication tried is actually less likely to help than the one prior.”
Click the link below to read the full article on Harvard Health’s blog.
Harvard University
Harvard Health Blog
2015
The researchers in this study analyze data from multiple studies to show how effective TMS can be for people with major depression. They conclude that the research done on TMS is very promising, and noted that TMS may be an option for people with depression-related disorders that would have originally been recommended for ECT.
Northwestern University
Neuropsychiatric Disease and Treatment, Dove Press
2009
“Up to 60% of obsessive-compulsive disorder (OCD) patients do not have a satisfactory outcome with currently available treatments . . . After 4 weeks, the response rate [to TMS treatment] was 67%.”
Columbia University
International Journal of Neuropsychopharmacology
2016
The doctors who compiled this research concluded that actual TMS was significantly more effective than the “sham” or placebo TMS.
Santa Casa School of Medical Sciences, São Paulo, Brazil; UCLA, Los Angeles, CA; Prince of Wales Hospital, Sydney, Australia; Institute of Psychiatry, Kolkata, India
Journal of ECT
2014
Targeted high-frequency stimulation with deep TMS may be effective in treating resistant OCD.
Cornell University
F1000 Prime Reports
2005
The study concludes that TMS is an effective treatment option for patients with major depressive disorder (MDD) and that it has rekindled the role of brain stimulation in psychiatric disorders.
Drexel University
Psychiatry Magazine
2013
Research concluded that transcranial magnetic stimulation (TMS) is an effective treatment for post-traumatic stress disorder (PTSD).
Dartmouth College
Brain Stimulation Journal
2014
Researchers discovered that no patients had persistent psychotomimetic effects, adverse medical effects, or increased substance use and concluded that ketamine is safe and well tolerated.
Icahn School of Medicine at Mount Sinai
The Journal of Clinical Psychiatry
2015
This study concluded that ketamine provides a rapid improvement in symptoms of depression, anxiety, PTSD, and other psychiatric conditions.
Yale University
Annals of the New York Academy of Sciences
2013
The study concluded that ketamine is a rapidly-acting drug and has the potential to revolutionize depression treatment, in particular treatment-resistant depression.
University of Pennsylvania
Frontiers in Pharmacology
Request Appointment